That Cancer Conversation · 2025-04-01 · 51 min
Welcome to another episode of That Cancer Conversation! In our last episode, ‘What are cancer vaccines?’ , Sophie spoke to Dr Heather Shaw to learn about cancer vaccines and how they work. In this second episode, we continue to dive deeper into the world of cancer vaccines to find out when we might see cancer vaccines as treatments for cancer. To start the conversation, Sophie speaks to Dr Lennard Lee, Associate Professor at University of Oxford and Chief Medical Officer of the EIT Institute, as well as co-founder of the NHS Cancer Vaccine Launch Pad . She also speaks to Cancer Research UK’s chief director of research and innovation, Dr Iain Foulkes, about how Cancer Research UK is playing a role in this ‘golden era’ of cancer treatments. If you enjoyed the episode, don't forget to subscribe and watch the new season all on our YouTube channel ! Extra links: The Cancer Vaccine Bulletin Discover more about cancer vaccines - > Cancer vaccines - where are we?
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio TherapeuticsCareTalk: Healthcare. Unfiltered. · on cancer94 / 100
#192 - Slowing Things Down to Speed Up Research with Jared Forney of OktaAwkward Silences · on research90 / 100
Why your research needs a “thinking cave” with Sarah KlingThe Curiosity Current: A Market Research Podcast · on research89 / 100
The Safest of Them All: What If Safe Assets Aren't Safe? (ft. Vincent Mortier, Group CIO of Amundi and Deputy CEO of Amundi AM)2050 Investors · on research81 / 100
Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on science76 / 100
Building Self-Accelerating AI with MirendilAI + a16z · on research65 / 100
